Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) EPS (Weighted Average and Diluted) (2022 - 2025)

Neuraxis (NRXS) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.17 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 19.05% to -$0.17 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.96 through Dec 2025, up 20.0% year-over-year, with the annual reading at -$0.95 for FY2025, 22.13% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.17 in Q4 2025 for Neuraxis, up from -$0.24 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.61 in Q4 2023 to a low of -$2.38 in Q3 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.56 across 4 years, with a median of -$0.32 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 971.43% in 2023 and later tumbled 134.43% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.07 in 2022, then surged by 971.43% to $0.61 in 2023, then crashed by 134.43% to -$0.21 in 2024, then grew by 19.05% to -$0.17 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for NRXS at -$0.17 in Q4 2025, -$0.24 in Q3 2025, and -$0.22 in Q2 2025.